Example #1: In connection with the Quarterly Report of Reach Messaging Holdings, Inc. (the “ Company ”) on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, Shane Gau, Chief Executive Officer of the Company, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Reach Messaging Holdings, Inc.', 'entity': 'Business'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Shane Gau', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #2: In connection with the Quarterly Report of InsPro Technologies Corporation (the `` Company '') on Form 10-Q for the fiscal quarter ended March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the `` Report ''), I, Anthony R. Verdi, Chief Executive Officer of the Company, certify that, based on my knowledge:
Expected output: 'entities: [{'span': 'InsPro Technologies Corporation', 'entity': 'Business'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Anthony R. Verdi', 'entity': 'Person'}]'

Example #3: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, Dan Kelly, Directors and Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'Dan Kelly', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #4: In connection with the Quarterly Report of InsPro Technologies Corporation (the `` Company '') on Form 10-Q for the fiscal quarter ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the `` Report ''), I, Anthony R. Verdi, Chief Financial Officer of the Company, certify, based on my knowledge:
Expected output: 'entities: [{'span': 'InsPro Technologies Corporation', 'entity': 'Business'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Anthony R. Verdi', 'entity': 'Person'}]'

Example #5: Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, to Kenneth L. Waggoner, Executive Vice President Legal, General Counsel and Director of the Company, 12526 High Bluff Drive, Suite 155, San Diego, California USA.
Expected output: 'entities: [{'span': 'Kenneth L. Waggoner', 'entity': 'Person'}, {'span': 'High Bluff Drive', 'entity': 'Location'}, {'span': 'San Diego', 'entity': 'Location'}, {'span': 'California', 'entity': 'Location'}, {'span': 'USA', 'entity': 'Location'}]'

Example #6: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #7: Linda Cvrkel Branch Chief United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E.
Expected output: 'entities: [{'span': 'Linda Cvrkel', 'entity': 'Person'}, {'span': 'United States Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'F Street', 'entity': 'Location'}, {'span': 'N.E.', 'entity': 'Location'}]'

Example #8: The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys ’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
Expected output: 'entities: [{'span': 'Court of Chancery of the State of Delaware', 'entity': 'Court'}, {'span': 'Court of Chancery', 'entity': 'Court'}]'

Example #9: A shareholder wishing to provide notice in the manner prescribed by Rule 14a-4 (c) (1) of a proposal submitted outside of the process of Rule 14a-8 for the annual meeting must, pursuant to each Fund s By-Laws, submit such written notice to the Fund not later than March 16, 2011 or prior to March 1, 2011.
Expected output: 'entities: []'

Example #10: The undersigned hereby makes, constitutes and appoints each of Michael J. Berner and Douglas W. Ambrose as the undersigned ’ s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16 (a) of the Securities Exchange Act of 1934, as amended (the “ 1934 Act ”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
Expected output: 'entities: [{'span': 'Michael J. Berner', 'entity': 'Person'}, {'span': 'Douglas W. Ambrose', 'entity': 'Person'}, {'span': 'United States Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Forms 3, 4 and 5', 'entity': 'Miscellaneous'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': '1934 Act', 'entity': 'Legislation/Act'}, {'span': 'Schedule 13D', 'entity': 'Miscellaneous'}, {'span': 'Schedule 13G', 'entity': 'Miscellaneous'}]'

Example #11: Under the Deferred Compensation Plan, Independent Board Members of the Participating Funds may defer receipt of all, or a portion, of the compensation they earn for their services to the Participating Funds, in lieu of receiving current payments of such compensation.
Expected output: 'entities: []'

Example #12: The number of regular quarterly meetings and special meetings held by the Board of each Fund during the Fund s last fiscal year is shown in Appendix C. During the last fiscal year, each Board Member attended 75 % or more of each Fund s Board meetings and the committee meetings (if a member thereof) held during the period for which such Board Member was a Board Member.
Expected output: 'entities: []'

Example #13: To request a separate copy of an annual report or proxy statement, or for instructions as to how to request a separate copy of such documents or as to how to request a single copy if multiple copies of such documents are received, shareholders should contact the applicable Fund at the address and phone number set forth above.
Expected output: 'entities: []'

Example #14: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #15: The following table sets forth, for each Board Member nominee and for the Board Member nominees and officers as a group, the amount of shares beneficially owned in each Fund as of December 31, 2009.
Expected output: 'entities: []'

Example #16: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #17: In January 2011, the FASB issued ASU 2011-01, Receivables (Topic 310): Deferral of the Effective Date of Disclosures about Troubled Debt Restructurings in Update No. The amendments in this Update temporarily delay the effective date of the disclosures about troubled debt restructurings in Update 2010-20, enabling public-entity creditors to provide those disclosures after the FASB clarifies the guidance for determining what constitutes a troubled debt restructuring.
Expected output: 'entities: [{'span': 'FASB', 'entity': 'Government'}, {'span': 'ASU', 'entity': 'Legislation/Act'}, {'span': 'Receivables', 'entity': 'Miscellaneous'}, {'span': 'Deferral of the Effective Date of Disclosures about Troubled Debt Restructurings', 'entity': 'Miscellaneous'}]'

Example #18: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #19: However, if other matters are properly presented to the Annual Meetings for a vote, the proxies will be voted by the persons acting under the proxies upon such matters in accordance with their judgment of the best interests of the Fund.
Expected output: 'entities: []'

Example #20: Research Analysts - JPMSI On April 28, 2003, the Commission filed a complaint (the “ JPMSI Research Analysts Complaint ”) against JPMSI in the United States District Court for the Southern District of New York (the “ New York District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'JPMSI', 'entity': 'Business'}, {'span': 'JPMSI Research Analysts Complaint', 'entity': 'Miscellaneous'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}, {'span': 'New York District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}]'

